Fragmented surface ECG was a poor predictor of appropriate therapies in patients with Chagas' cardiomyopathy and ICD implantation (fragmented ECG in CHAgas' cardiomyopathy study)

Annals of Noninvasive Electrocardiology

Volumn 19, Issue 1, 2014, Pages 43-49

  Baranchuk, Adrian ^a   Femenia, Francisco ^b   López Diez, Juan Cruz ^c   Muratore, Claudio ^d   Valentino, Mariana ^e   Retyk, Enrique ^f   Galizio, Nestor ^g   Di Toro, Darío ^h   Alonso, Karina ⁱ   Hopman, Wilma M ^a   Miranda, Rodrigo ^j  

^a QUEEN S UNIVERSITY   (Canada)

^b HOSPITAL ESPAÑOL   (Argentina)

^c HOSPITAL MILITAR CENTRAL   (Argentina)

^d HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^e Sanatorio Parque   (Argentina)

^f Castex Hospital   (Argentina)

^g HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^h HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

ⁱ Sanatorio Franchin ^*  (Argentina)

^j UNIVERSIDAD DE LA FRONTERA   (Chile)

more..

Author keywords

Chagas' disease; fragmented ECG; implantable cardioverter defibrillator; sudden death; ventricular arrhythmias

Indexed keywords

AMIODARONE; SPIRONOLACTONE;

ADULT; AGING; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CHAGAS DISEASE; CONVULSIVE THERAPY; ELECTROCARDIOGRAM; FEMALE; FUNCTIONAL STATUS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; PRIMARY PREVENTION; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SUDDEN CARDIAC DEATH; SUDDEN DEATH; SURFACE FRAGMENTED ELECTROCARDIOGRAM; TREATMENT INDICATION; ARRHYTHMIAS, CARDIAC; CHAGAS CARDIOMYOPATHY; CLINICAL TRIAL; COMPLICATION; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HEART MUSCLE CONDUCTION SYSTEM; PROCEDURES; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ARRHYTHMIAS, CARDIAC; CHAGAS CARDIOMYOPATHY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84893710095     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/anec.12077     Document Type: Article

References (30)

1. World Health Organization. Control of Chagas' disease. Report of a WHO Expert Committee, Technical Report Series 811, Geneva, 1991.
2. Rosenbaum MB,. Chagasic myocardiopathy. Prog Cardiovasc Dis 1964; 7: 199-225.
3. Muratore CA, Baranchuk A,. Current and emerging therapeutic options for the treatment of chronic Chagasic cardiomyopathy. Vasc Health Manag Risk 2010; 6: 593-601.
4. Dias E, Laranja FS, Miranda A, et al. Chagas' disease: A clinical, epidemiologic and pathologic study. Circulation 1956; 14: 1035-1060.
5. Baranchuk A, Rosas F, Morillo CA,. Enfermedad de Chagas en Países Desarrollados: Mito o Realidad (Chagas' disease in developed countries: myth or reality). In, Rosas F, Vanegas D, Cabrales M, (eds.): Enfermedad de Chagas. Bogota, Sociedad Colombiana de Cardiología, Sociedad Española de Cardiología, 2007. p 217-219.
6. Cardinalli-Neto A, Greco O, Bestetti R,. Automatic implantable cardioverter-defibrillators in Chagas heart disease patients with malignant ventricular arrhythmias. Pacing Clin Electrophysiol 2006; 29: 467-470.
7. Muratore C, Batista Sa L, Chiale P, et al. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America. Europace 2009; 11: 164-168.
8. Cardinalli-Neto A, Nakazone MA, Grassi LV, et al. Implantable cardioverter-defibrillator therapy for primary prevention of sudden cardiac death in patients with severe Chagas cardiomyopathy. Int J Cardiol 2011; 150: 94-59.
9. Di Toro D, Muratore CA, Aguinaga L, et al. Predictors of all-cause 1 year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy. Pacing Clin Electrophysiol 2011; 34: 1063-1069.
10. Cardinalli-Neto A, Bestetti RB, Cordeiro JA, et al. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy. J Cardiovasc Electrophysiol 2007; 18: 1236-1240.
11. Das MK, Saha C, El Masry H, et al. Fragmented QRS on a 12-lead ECG: a predictor of mortality and cardiac events in patients with coronary artery disease. Heart Rhythm 2007; 4: 1385-1392.
12. Das MK, Suradi H, Maskoun W, et al. Fragmented wide QRS on a 12-lead ECG: A sign of myocardial scar and poor prognosis. Circ Arrhythmia Electrophysiol 2008; 1: 258-268.
13. Das MK, El Masry H,. Fragmented QRS and other depolarization abnormalities as a predictor of mortality and sudden cardiac death. Curr Opin Cardiol 2010; 25: 59-64.
14. Das MK, Maskoun W, Shen C, et al. Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy. Heart Rhythm 2010; 7: 74-80.
15. Peters S,. QRS fragmentation as a marker of arrhythmias in coronary artery disease, in cardiomyopathies and ion channel diseases. Int J Cardiol 2012; 158: 176-177.
16. Femenia F, Arce M, Arrieta M, et al. Surface fragmented QRS in a patient with hypertrophic cardiomyopathy and malignant arrhythmias: Is there an association? J Cardiovasc Dis Res 2012; 3: 32-35.
17. Sakane K, Takaki H, Okamura H, et al. Visualization of intra-QRS fragmented activation in patients with hypertrophic cardiomyopathy and life-threatening ventricular arrhythmia using magnetocardiography. Eur Heart J 2011; 32 (Suppl. 1): 155.
18. Sha J, Zhang S, Tang M, Chen K, Zhao X, Wang F,. Fragmented QRS is associated with all-cause mortality and ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Ann Noninvasive Electrocardiol 2011; 16: 270-275.
19. Basaran Y, Tigen K, Karaahmet T, et al. Fragmented QRS complexes are associated with cardiac fibrosis and significant intraventricular systolic dyssynchrony in nonischemic dilated cardiomyopathy patients with a narrow QRS interval. Echocardiography 2011; 28: 62-68.
20. Peters S, Trümmel M, Koehler B,. QRS fragmentation in standard ECG as a diagnostic marker of arrhythmogenic right ventricular displasia cardiomyopathy. Heart Rhythm 2008; 5: 1417-1421.
21. Peters S, Trümmel M, Koehler B,. Prognostic value of QRS fragmentation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Med 2012; 13: 295-298.
22. Priori SG, Gasparini M, Napolitano C, et al. Risk stratification in Brugada syndrome: Results of the PRELUDE (PRogrammed ELectrial stimUlation preDictive valuE) registry. J Am Coll Cardiol 2012; 59: 37-45.
23. Haraoka K, Morita H, Saito Y, et al. Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome. Heart Rhythm 2010; 7: 1808-1814.
24. Homsi M, Alsayed L, Das MK, et al. Fragmented QRS complexes ona 12-lead ECG is a marker of greater myocardial scarring related to coronary artery disease by magnetic resonance imaging. J Am Coll Cardiol 2008; 51: A31.
25. Homsi M, Alsayed L, Das MK, et al. Fragmented QRS complexes on a 12-lead ecg is a marker of greater myocardial scarringd related to non-coronary artery diseases by magnetic resonance imaging. J Am Coll Cardiol 2009; 53: A140.
26. Das MK, Michael MA, Suradi H, et al. Usefulness of fragmented QRS on a 12-lead electrocardiogram in acute coronary syndrome for predicting mortality. Am J Cardiol 2009; 104: 1631-1637.
27. Das MK, Zipes DP,. Fragmented QRS: A predictor of mortality and sudden cardiac death. Heart Rhythm 2009; 6: S8-14.
28. Parada H, Carrasco H, Guerrero L, et al. Diferencias clínicas y paraclínicas entre la miocardiopatia chagasica crónica y las miocardiopatias dilatadas primarias. Arq Bras Cardiol 1989; 53: 99-104.
29. Femenia F, Cuesta A, Arce M,. A rare form of trifascicular block with intermittent complete atrioventricular block in a patient with Chagas disease. Cardiol J 2009; 6: 582-584.
30. Dubner S, Schapachnik E, Riera AR, et al. Chagas disease: State-of-the-art diagnosis and management. Cardiol J 2008; 15: 493-504.